Method of performing angioplasty with a GLP-1 molecule

Details Method of performing angioplasty with a GLP-1 molecule Method of performing angioplasty with a GLP-1 molecule

2011-07-19

2011-07-19

Kosson, Rosanne (Department: 1652)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S011700, C514S021300, C530S308000, C530S324000, C604S509000

Reexamination Certificate

active

07981861

ABSTRACT:
The invention relates to methods for treating a patient suffering from acute coronary syndrome, but who is not suffering from a Q-wave myocardial infarction, comprising administration of a therapeutically effective amount of a GLP-1 molecule. The GLP-1 can be self-administered, and can be administered in one or more doses, as needed, on an intermittent or continuous basis, to optimize metabolism in cardiac tissue and to prevent cardiac damage associated with ischemia.

REFERENCES:
patent: 5424286 (1995-06-01), Eng
patent: 5837008 (1998-11-01), Berg et al.
patent: 6277819 (2001-08-01), Efendic
patent: 6348447 (2002-02-01), Hellstrom et al.
patent: 6358924 (2002-03-01), Hoffmann
patent: 6376549 (2002-04-01), Fine et al.
patent: 6448045 (2002-09-01), Levine et al.
patent: 6471968 (2002-10-01), Baker et al.
patent: 6830932 (2004-12-01), Danne et al.
patent: 2003/0040469 (2003-02-01), Knudsen
patent: 1566180 (2005-08-01), None
patent: WO 98/08531 (1998-03-01), None
patent: WO 98/43658 (1998-10-01), None
patent: WO 00/16797 (2000-03-01), None
patent: WO 00/66138 (2000-11-01), None
patent: WO 00/66142 (2000-11-01), None
patent: WO 01/66135 (2001-09-01), None
Apstein,Circulation98:2223-2226 (1998):Glucose-Insulin-Potassium for Acute Myocardial Infarction: Remarkable Results from a New Prospective, Randomized Trial.
Aronson et al.,Ann. Intern. Med. 126:296-306 (1997):Mechanisms defining course and outcome of diabetic patients who have had acute myocardial infarction.
Barragan et al.,Regulatory Peptides67:63-68 (1996):Interactions of Exendin-(9-39)with the effects of glucagon-like Peptide-1-(7-36)amide and of Exendin-4 on arterial blood pressure and heart rate in rats.
Bose at al.,Diabetes54:146-151 (Jan. 2005):Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.
Frost et al.,Nutrition15(3):183-188 (Mar 1999):Effect of large bowel fermentation on insulin, glucose, free fatty acids and glucagon-like peptide1(7-36)amide in patients with coronary heart disease.
Nikolaidis et al.,J. Am. Coll. Cardiol. 37(2):Suppl. 1:218A (Feb 2001):GLP-1 improves myocardial performance in conscious dogs with pacing induced heart failure.
Theroux et al.,Circulation97(12):1195-1206 (1998):Acute coronary syndromes, unstable angina and Non-Q-wave myocardial infarction.

Affiliated with

Also associated with

Rating

Method of performing angioplasty with a GLP-1 molecule does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of performing angioplasty with a GLP-1 molecule, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of performing angioplasty with a GLP-1 molecule will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2719185